The ALK gene is situated in proximity to MYCN and ALKAL2 on chromosome 2p and it has been argued that co-amplification of these three explains the inferior outcome in neuroblastoma patients with 2p gain [85]. This evidence concerns the gene MYCN and neuroblastoma.